作者：
Goss,P.E. [1]
;
Ingle,J.N. [2]
;
Pritchard,K.I. [3]
;
Ellis,M.J. [4]
;
Sledge,G.W. [5]
;
Budd,G.T. [6]
;
Rabaglio,M. [7]
;
Ansari,R.H. [8]
;
Johnson,D.B. [9]
;
Tozer,R. [10]
;
D'Souza,D.P. [11]
;
Chalchal,H. [12]
;
Spadafora,S. [13]
;
Stearns,V. [14]
;
Perez,E.A. [15]
;
Liedke,P.E.R. [16]
;
Lang,I. [17]
;
Elliott,C. [18]
;
Gelmon,K.A. ;
Chapman,J.-A.W. ;
Shepherd,L.E.
作者单位：
NCIC Clinical Trials Group, Kingston, ON, Canada
[1]
Northern Indiana Cancer Research Consortium, South Bend, IN, United States
[2]
Mayo Clinic, Rochester, MN, United States
[3]
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, United States
[4]
British Columbia Cancer Agency, Vancouver, BC, Canada
[5]
Juravinski Cancer Centre, Hamilton, ON, Canada
[6]
Massachusetts General Hospital, Cancer Center, Lawrence House, 55 Fruit St, LRH-302, Boston, MA
[7]
Siteman Cancer Center, Washington University, St Louis, MO, United States
[8]
Cancer Center of Kansas, Wichita, KS, United States
[9]
London Regional Cancer Program, London, ON, Canada
[10]
National Institute of Oncology, Budapest, Hungary
[11]
Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada
[12]
International Breast Cancer Study Group Coordinating Center, Inselspital, Bern, Switzerland
[13]
Cleveland Clinic, Cleveland, OH, United States
[14]
Regina General Hospital, Regina, SK, Canada
[15]
Mayo Clinic, Jacksonville, FL, United States
[16]
Indiana University Health, Indianapolis, IN, United States
[17]
Algoma Regional Cancer Centre, Sault St Marie, ON, Canada
[18]
发布时间
2013-11-20
换一批
换一批
